This protocol is judged by an institutional review board, an impartial group that opinions any medical trials involving individuals. If a study consists of a Timetable I drug, after the board approves the protocol as ethical, the researchers must make an application for an investigational new drug (IND) selection from the FDA.Medicines may also in